VR Logo

Wanbury Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1988

Chairman: --

Managing Director: --

Group: --

Listing: NSE: WANBURY, BSE: 524212

Headquarters: Navi Mumbai, Maharashtra

Website: www.wanbury.com

Key Facts

Market cap: R 59.36 Cr

Revenue (TTM): R 401.97 Cr

Earnings (TTM): R -7.81 Cr

Cash: R 5.25 Cr

Total Debt: R 232.99 Cr

Promoters' ownership: 52.13%

Liquidity: Moderate

52 Week range: R 10.75 - 33.40

Face value: R10.00

Shares outstanding: 2,49,95,117

10 Years Aggregate:

  • CFO: 532.50 Cr
  • EBITDA: -22.47 Cr
  • Net Profit: -327.99 Cr

Stock Performance

Time Period Wanbury S&P BSE Healthcare S&P BSE Small Cap
YTD26.6721.85-6.67
1 month17.572.176.85
3 months15.5716.6828.11
1 Year83.8230.34-7.32
3 Years-20.324.38-6.86
5 Years-15.12-0.602.40
10 Years-12.0211.023.30
As on 08-Jul-2020
Year Wanbury S&P BSE Small Cap S&P BSE Healthcare
2019-9.27-6.85-3.55
2018-53.97-23.41-5.89
2017-27.9259.640.49
2016-29.881.77-12.88
2015214.906.7615.06
20149.7969.2447.43
201310.33-11.2322.55

Review & Analysis